Evidence map›Paper›PMID 30824688›Full record

ArticleCell death & disease2019

Publisher Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling.

Shanshan Wang, Mingyue Zhu, Qiaoyun Wang, Yuli Hou, Lei Li, Honglei Weng, Yan Zhao, Dexi Chen, Junli Guo, Huiguo Ding and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Shanshan WangBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Mingyue ZhuHainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical College, Haikou, China.
Qiaoyun WangHainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical College, Haikou, China.
Yuli HouClinical Laboratory Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Lei LiDepartment of Gastrointestinal and Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Honglei WengMolecular Hepatology, University of Heidelberg, University Medical Center Mannheim, 68167, Mannheim, Germany.
Yan ZhaoClinical Laboratory Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Dexi ChenBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Junli GuoHainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical College, Haikou, China.
Huiguo DingDepartment of Gastrointestinal and Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China. dinghuiguo@medmail.com.cn.
Mengsen LiHainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical College, Haikou, China. mengsenli@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The article published with errors in the authors' information. The correct ordering and designations for corresponding /first authors are shown here.

Identifiers

PMID30824688
PMCPMC6397264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.